Early ribavirin reduce RSV symptoms duration in post-allogeneic stem cell transplant: challenges in symptoms duration assessment

IF 4.5 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2025-03-22 DOI:10.1038/s41409-025-02549-7

José Luis Piñana, Mireia Micó-Cerdà, Dolores Gómez, Ariadna Pérez, Juan Montoro, Rafael Hernani, Pedro Chorão, Juan Carlos Hernández-Boluda, David Navarro, Carlos Solano

引用次数: 0

Abstract Image

查看原文本刊更多论文

早期利巴韦林减少同种异体干细胞移植后RSV症状持续时间：症状持续时间评估的挑战

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.